EE+ POEM Archive
Bamlanivimab plus etesevimab reduces the likelihood of hospitalization or death in high-risk outpatients with COVID-19 (NNT = 20)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Bamlanivimab Plus Etesevimab Reduces the Likelihood of Hospitalization or Death in High-risk Outpatients With COVID-19 (NNT = 20)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315499/all/Bamlanivimab_plus_etesevimab_reduces_the_likelihood_of_hospitalization_or_death_in_high_risk_outpatients_with_COVID_19__NNT_=_20_.
Bamlanivimab plus etesevimab reduces the likelihood of hospitalization or death in high-risk outpatients with COVID-19 (NNT = 20). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315499/all/Bamlanivimab_plus_etesevimab_reduces_the_likelihood_of_hospitalization_or_death_in_high_risk_outpatients_with_COVID_19__NNT_=_20_. Accessed April 25, 2024.
Bamlanivimab plus etesevimab reduces the likelihood of hospitalization or death in high-risk outpatients with COVID-19 (NNT = 20). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315499/all/Bamlanivimab_plus_etesevimab_reduces_the_likelihood_of_hospitalization_or_death_in_high_risk_outpatients_with_COVID_19__NNT_=_20_
Bamlanivimab Plus Etesevimab Reduces the Likelihood of Hospitalization or Death in High-risk Outpatients With COVID-19 (NNT = 20) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315499/all/Bamlanivimab_plus_etesevimab_reduces_the_likelihood_of_hospitalization_or_death_in_high_risk_outpatients_with_COVID_19__NNT_=_20_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bamlanivimab plus etesevimab reduces the likelihood of hospitalization or death in high-risk outpatients with COVID-19 (NNT = 20)
ID - 1315499
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315499/all/Bamlanivimab_plus_etesevimab_reduces_the_likelihood_of_hospitalization_or_death_in_high_risk_outpatients_with_COVID_19__NNT_=_20_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
